Search research articles
Contact Us
Filters
Showing results (31-40 of 81) with videos related to
Page
of 9
Sort By:
IET Nanobiotechnology
|
January 15, 2020
High-efficiency Ni<sup>2+</sup>-NTA/PAA magnetic beads with specific separation on His-tagged protein
Wenjing Wang, Fengzhen Zhou, Xiyao Cheng, et al.
Biomolecules
|
July 29, 2025
Research Progress on the Functional Regulation Mechanisms of ZKSCAN3
Jianxiong Xu, Xinzhe Li, Jingjing Xia, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 11, 2026
A new liver-targeted agonist of thyroid hormone receptor beta resmetirom in treating MASLD/MASH: from mechanism to therapy
Monan Liu, Ye Ma, Wai San Cheang, et al.
Journal of the American Chemical Society
|
December 3, 2014
Efficient reactivation of p53 in cancer cells by a dual MdmX/Mdm2 inhibitor
Lingyun Qin, Fei Yang, Cindy Zhou, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 20, 2020
The structure and phase of tau: from monomer to amyloid filament
Yifan Zeng, Jing Yang, Bailing Zhang, et al.
Cell Biochemistry and Biophysics
|
February 10, 2022
14-3-3 Proteins are Potential Regulators of Liquid-Liquid Phase Separation
Xianlong Huang, Zhiwen Zheng, Yixin Wu, et al.
Genes & Diseases
|
April 10, 2026
Emerging roles of the metabolic regulator 3-hydroxy-3-methylglutaryl coenzyme-CoA reductase in human cancers: From biology to therapeutics
Wenfang Li, Jianxiong Xu, Yuxuan Long, et al.
Microbial Cell Factories
|
January 30, 2023
Loop pathways are responsible for tuning the accumulation of C19- and C22-sterol intermediates in the mycobacterial phytosterol degradation pathway
Shikui Song, Jianxin He, Meng Gao, et al.
Frontiers in Oncology
|
March 29, 2021
Dual Inhibition of Ornithine Decarboxylase and A<sub>1</sub> Adenosine Receptor Efficiently Suppresses Breast Tumor Cells
Hongyan Ma, Qizhang Li, Jing Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 19, 2026
The Warburg effect and beyond: Glycolytic reprogramming in cancer progression and emerging therapeutic strategies
Yuxuan Long, Jianxiong Xu, Zenan Xu, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 81) with videos related to
Sort By:
Page
of 9
IET Nanobiotechnology
|
January 15, 2020
High-efficiency Ni<sup>2+</sup>-NTA/PAA magnetic beads with specific separation on His-tagged protein
Wenjing Wang, Fengzhen Zhou, Xiyao Cheng, et al.
Biomolecules
|
July 29, 2025
Research Progress on the Functional Regulation Mechanisms of ZKSCAN3
Jianxiong Xu, Xinzhe Li, Jingjing Xia, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 11, 2026
A new liver-targeted agonist of thyroid hormone receptor beta resmetirom in treating MASLD/MASH: from mechanism to therapy
Monan Liu, Ye Ma, Wai San Cheang, et al.
Journal of the American Chemical Society
|
December 3, 2014
Efficient reactivation of p53 in cancer cells by a dual MdmX/Mdm2 inhibitor
Lingyun Qin, Fei Yang, Cindy Zhou, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 20, 2020
The structure and phase of tau: from monomer to amyloid filament
Yifan Zeng, Jing Yang, Bailing Zhang, et al.
Cell Biochemistry and Biophysics
|
February 10, 2022
14-3-3 Proteins are Potential Regulators of Liquid-Liquid Phase Separation
Xianlong Huang, Zhiwen Zheng, Yixin Wu, et al.
Genes & Diseases
|
April 10, 2026
Emerging roles of the metabolic regulator 3-hydroxy-3-methylglutaryl coenzyme-CoA reductase in human cancers: From biology to therapeutics
Wenfang Li, Jianxiong Xu, Yuxuan Long, et al.
Microbial Cell Factories
|
January 30, 2023
Loop pathways are responsible for tuning the accumulation of C19- and C22-sterol intermediates in the mycobacterial phytosterol degradation pathway
Shikui Song, Jianxin He, Meng Gao, et al.
Frontiers in Oncology
|
March 29, 2021
Dual Inhibition of Ornithine Decarboxylase and A<sub>1</sub> Adenosine Receptor Efficiently Suppresses Breast Tumor Cells
Hongyan Ma, Qizhang Li, Jing Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 19, 2026
The Warburg effect and beyond: Glycolytic reprogramming in cancer progression and emerging therapeutic strategies
Yuxuan Long, Jianxiong Xu, Zenan Xu, et al.
Page
of 9